Acalabrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia: updated phase 2 results

Autor: Byrd, John C. 1, 1, *, Wierda, William G. 2, Schuh, Anna 3, Devereux, Stephen 4, Chaves, Jorge M. 5, Brown, Jennifer R. 6, Hillmen, Peter 7, Martin, Peter 8, Awan, Farrukh T. 9, Stephens, Deborah M. 10, Ghia, Paolo 11, 12, Barrientos, Jacqueline 13, Pagel, John M. 14, Woyach, Jennifer A. 1, Burke, Kathleen 15, Covey, Todd 16, Gulrajani, Michael 16, Hamdy, Ahmed 16, Izumi, Raquel 16, Frigault, Melanie M. 16, Patel, Priti 16, Rothbaum, Wayne 16, Wang, Min Hui 16, O'Brien, Susan 17, *, Furman, Richard R. 8, *
Zdroj: In Blood 9 April 2020 135(15):1204-1213
Databáze: ScienceDirect